Rigel Pharmaceuticals, Inc. (RIGL) NASDAQ

39.94

+1.99(+5.24%)

Updated at November 12 04:00PM

Currency In USD

Valuation

Market Cap295.68M
Enterprise Value298.9M
P/E Ratio6.36
PEG Ratio0.42
Price/Sales Ratio2.53
Price/Book Ratio6.13
Enterprise/Revenue2.57
Enterprise/EBITDA5.91

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.4
Operating Margin0.42

Management Effectiveness

Return On Assets0.47
Return On Equity2.05

Income Statement

Revenue179.28M
Revenue/Share15.64
Gross Profit160.63M
EBITDA28.51M
Net Income17.49M
Diluted EPS0.99

Balance Sheet

Total Cash137.14M
Total Cash/Share7.6
Total Debt60.88M
Total Debt/Equity0.52
Current Ratio2.28
Book Value Per Share6.52

Price History

52-Week Change45.71
52-Week High43.72
52-Week Low14.63
Moving Average 50 Days32.18
Moving Average 200 Days24.58

Statistics

Average Volume682,850
Shares Outstanding17.85M
% Held by Institutions77.64

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateJune 27, 2024